Unilabs acquires Alpha Medical, a leading medical diagnostics company in Slovakia and the Czech Republic, two important Eastern European markets
Geneva, Bratislava, London, 9th February 2017. Geneva based Unilabs today announced that it has reached an agreement to acquire Alpha Medical, a leading medical diagnostics company serving customers in Slovakia and the Czech Republic, from private equity firm Mid Europa Partners for an undisclosed amount.
Alpha Medical has grown to become one of the most advanced laboratory diagnostics providers in Eastern Europe. The company has a market-leading reputation, offering a full service lab diagnostics solution for its customers.
Jos Lamers, CEO of Unilabs said: “This is an important foray into Eastern European markets for Unilabs. After a strong focus on generating organic growth, this acquisition signals our return to making smart acquisitions, aligned with our services portfolio and high-end quality standards. We look forward to welcoming the new teams from Alpha Medical to the Unilabs family.”
Peter Lednický, CEO of Alpha Medical commented: “We are delighted to have found a true strategic partner through this deal. We have been through a similar journey to Unilabs, focussing on operational excellence and developing a comprehensive services portfolio, within our own markets Slovakia and Czech Republic. This is a great opportunity to accelerate our growth via the exchange of best practices and the support of an internationally recognised brand.”
Steven Dyson, chairman of Unilabs and Co-head of Healthcare at Apax Partners, concluded: “Alpha Medical is the ideal partner for Unilabs, further diversifying market presence into Eastern Europe. Through this deal we will have a strong platform to fuel further growth, in both Alpha Medical’s existing markets and new opportunities in the region.”
The finalisation of the deal is subject to approval by regulatory authorities in Slovakia and the Czech Republic.
NOTES TO EDITORS:
In the Czech Republic, the Alpha medical group operates under its AeskuLab brand.
Tel. +44 77 41 26 06 54
With over 112 laboratories and 43 imaging units and a broad catalogue of more than 2,500 diagnostic tests, Unilabs is one of Europe’s leading providers of clinical laboratory testing and medical diagnostic imaging services. Headquartered in Geneva, the Unilabs Group services sectors ranging from private and public healthcare providers to local governments, from pharmaceutical companies to the general public. The company employs more than 5,300 people worldwide, successfully operating laboratory and medical diagnostic imaging facilities in 12 countries, and generating annual revenues of €673m in 2015. Its network of facilities provides its customers with one of the broadest geographic footprints of any clinical laboratory and medical diagnostic services provider in Europe.
We are at the heart and start of all effective treatment decisions: www.unilabs.com
About Alpha Medical
Alpha Medical is the #1 provider of laboratory diagnostics in the Czech Republic and Slovakia, performing more than 55 million tests annually across a well-invested network employing over 1,500 people. The Company provides a full range of routine and specialised tests, mainly in the areas of biochemistry, microbiology, pathology and genetics, and operates a fully integrated procurement and workflow system. Alpha Medical's operations are organized around a highly efficient network of 93 labs, of which 7 are large central labs which utilize automated testing equipment. All central labs and most satellite labs have the highest level of ISO accreditation, with standardized processes ensuring industry leading quality standards across all testing facilities. Alpha Medical’s lab network is served by a proprietary 300-vehicle logistics fleet with significant geographic coverage and route density, facilitating proximity to customers and fast testing times.
About Apax Partners LLP
Apax Partners LLP is a leading global private equity advisory firm. Over its more than 30-year history, Apax Partners LLP has raised and advised funds with aggregate commitments in excess of $48 billion*. Funds advised by Apax Partners LLP invest in companies across four global sectors of Healthcare, Tech and Telco, Services and Consumer. These funds provide long-term equity financing to build and strengthen world-class companies. In the healthcare sector they have completed more than 80 investments, including in medical devices, pharmaceuticals and healthcare services.
For further information please seewww.apax.com
*Funds raised since 1981, commitments converted from fund currency to USD at FX rates as at September 30, 2016.